Clinical Trials Logo
  1. Home
  2. Hepatitis C
  3. NCT03980301
  4. Details
NCT03980301 Clinical Trial

Screening Hepatitis Positive Women for Congenital Anomalies

Hepatitis C Clinical Trial

Official title:
Screening Hepatitis Positive Women for Congenital Anomalies During Pregnancy and Assessment of Liver Status of Women

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03980301
Other study ID # hepatitis
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 11, 2018
Est. completion date October 20, 2020

Study information
Verified date October 2020
Source Aljazeera Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Hepatitis C virus is one of the virulent viruses

Description:

Hepatitius positive women should be screened for congenital anomalies

Recruitment information / eligibility
Status Completed
Enrollment 200
Est. completion date October 20, 2020
Est. primary completion date June 15, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Pregnant women with hepatitis C virus received treatment during first trimester Exclusion Criteria: - pregnant women with hepatitis C virus who didnot receive treatment during first trimester

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• ultrasound
screening of pregnant women with hepatitis c virus received treatment in first trimester for congenital anomalies

Locations
Country Name City State
Egypt Algazeerah Giza

Sponsors (2)
Lead Sponsor Collaborator
Aljazeera Hospital National Research Center, Egypt

Country where clinical trial is conducted

Egypt, 

Outcome
Type Measure Description Time frame Safety issue
Primary the number of pregnant women who will be diagnosed to have fetuses with congenital anomalies the number of pregnant women who will be diagnosed to have fetuses with congenital anomalies by us within 6 months
See also
  Status Clinical Trial Phase
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Recruiting NCT04510246 - Link Hepatitis C Notifications to Treatment in Tasmania N/A
Completed NCT03413696 - Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients
Completed NCT03109457 - Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma
Completed NCT03118674 - Harvoni Treatment Porphyria Cutanea Tarda Phase 2
Completed NCT01458054 - Effect of Omeprazole and Ritonavir on GSK2336805 Pharmacokinetics in Healthy Adults Phase 1
Completed NCT03740230 - An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New Drugs
Completed NCT03426787 - Helping Empower Liver and Kidney Patients N/A
Completed NCT03627299 - Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors Phase 4
Completed NCT00006301 - Immune Response to Hepatitis C Virus
Active, not recruiting NCT03949764 - The Kentucky Viral Hepatitis Treatment Study Phase 4
Completed NCT03365635 - Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C Phase 4
Recruiting NCT04405024 - Pilot Study on the Feasibility of Systematic Hepatitis C Screening of Hospitalized Patients N/A
Completed NCT04525690 - Improving Inpatient Screening for Hepatitis C N/A
Completed NCT04033887 - Evaluation Study of RDTs Detecting Antibodies Against HCV
Withdrawn NCT04546802 - HepATocellular Cancer Hcv Therapy Study Phase 3
Active, not recruiting NCT02961426 - Strategic Transformation of the Market of HCV Treatments Phase 2/Phase 3
Completed NCT02705534 - Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1 Phase 3
Completed NCT02869776 - Integrating HCV and HIV Screening During the Era of HIV Antigen Testing N/A
Completed NCT02992184 - PoC-HCV Genedrive Viral Detection Assay Validation Study N/A